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Abstract
Autism is a neuropsychiatric disorder with profound family and social consequences. An extraordinary number of genetical-
clinical, cytogenetics and molecular studies were done in recent years. A multiloci epistatic model involved in the causation of
autism have emerged from these studies.
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Resumo
O autismo é uma doença neuropsiquiátrica com profundas conseqüências sociofamilares. Inúmeros trabalhos investigaram paci-
entes e famílias com metodologia genético-clínica, citogenética e biologia molecular. Os resultados destes trabalhos apontam para
um modelo multiloci com interação epistática associado à etiologia do autismo.
Descritores: Transtorno autístico/genética; Transtornos  cromossômicos; Aberrações cromossômicas; Deficiências do desenvolvi-
mento; Genes.
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Introduction
For more than three decades, there has been crucial evidence
that most psychiatric disorders, including schizophrenia, bipolar
disorder and autism, have a strong genetic component. In the
last 15 years, innumerable gene loci have been associated with
these and other mental disorders, principally through genetic
linkage analysis. However, only a few specific genes have been
identified. Most of these genes can only be identified when literally
hundreds of affected individuals and their relatives are analyzed.
Promising new research techniques and methods have emerged
that might further the investigation of the genetic and
environmental causes of these disorders.
Advances in human genetics research have paved the way for
increasing knowledge of the biological pathways of cognitive and
affective disorders, as well as of certain types of psychoses. Due
to the great difficulty in comprehending alterations in encephalic
functions, understanding the physiopathology of the nervous
system has become highly attractive. As previously mentioned,
studies of families with one or more affected members, as well
as twin and adoption studies, have shown that mental disorders
such as autism have a strong genetic component.1 However,
none of these diseases follow a Mendelian inheritance pattern,
which suggests interaction among multiple genes.
The autistic phenotype is broadly varied. Individuals with classic
autism, lacking verbal communication and presenting severe men-
tal deficiency, as well as autistic individuals presenting verbal abilities
and normal intelligence, have been described. Developmental
abnormalities are usually detected in the first three years of life
and persist into adulthood.2 The Diagnostic and Statistical Manual
of Mental Disorders4 and the International classification of diseases5
created the diagnostic category of Global Development Disorders
and Pervasive Developmental Disorders (PDDs). In general, these
are all designated as autism. The PDDs affect social interaction,
communication and behavior and are highly prevalent, up to 5
cases per 1000 children, with a 4:1 male/female ratio.3,6-8
The etiology of autism is still unknown. Hundreds of studies have
been conducted in attempts to reveal the genetic factors associated
with the disease. The neurobiological causes associated with autism,
such as convulsions, mental deficiency, fewer neurons and synapses
in the amygdala, hippocampus and cerebellum;9 encephalitis,9 and
a higher concentration of circulating serotonin, suggest a strong
genetic component. In fact, studies with twins have actually shown
that the concordance with autism ranges from 36% to 92% in
monozygotic (MZ) twins, whereas concordance is low or null in
dizygotic (DZ) twins.10 However, when cognitive and social
abnormalities are considered, the level of concordance rises to 92%
among MZ twins and 10% among DZ twins.11 Another relevant
fact is that, although the risk of autism recurrence is low (2%-8%),
the relative risk is 50-200 times greater than the prevalence of the
disorder in the general population.6,12
It is believed that there are from 3 to more than 10 genes
related to the disease.13-14 Furthermore, the autism spectrum can
be found in practically all chromosome abnormalities.15 The
15q11-13 region, critical in the Prader-Willi/Angelman syndrome,
shows alteration in 1% to 4% of autistic patients.16 Structural
incoherencies in the 17p11.2 region, critical in the Smith-
Magenis syndrome, have also been reported in autistic
individuals.17 Likewise, patients with tuberous sclerosis, Rett
syndrome, phenylketonuria, neurofibromatosis or autism-related
fragile X syndrome form etiological subgroups.7,18 Approximately
30% of fragile X individuals present the autism spectrum.6,19
However, there is discordance on the degree of prevalence of
fragile X in autism patients, ranging from 7%-8%.20-21
The first extensive triage of the complete genome for
chromosomal regions involved in classic autism found
approximately 354 associated genetic markers, located in 8 regions
of the following chromosomes: 2, 4, 7, 10, 13, 16, 19 and
22.22 However, later studies have shown that the 7q, 16p, 2q,
17q regions are the most significant.23 More recent studies have
provided evidence of linkage with the X chromosome.24-25
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Genes identified in patients with autism, such as developmental
genes associated with the central nervous system,26-27 genes in
the serotonin system and in other systems regulating neuron
function, as well as genes located at chromosomal breakpoints,28
have arisen as candidate genes. In the 15q11-13 region, for
example, the cluster of the gamma-aminobutyric acid receptor
gene seems to be associated with autism pathogenesis.7,28 In
addition, expression of the UBE3A gene is predominant in the
human brain.30-31 However, since individuals with chromosomal
alterations in this region are not always autistic, it is believed that
the changes in these genes are not sufficient to induce development
of the disease. This hypothesis reinforces that of autism originating
from synergism or epistasis among multiple genes.
Most studies have focused on the 7q22-q33 region. In the
7q22 region, the RELN (previously reelin) gene, which encodes
a glycoprotein extensively secreted in neuronal migration, may
present alterations that affect cortical and cerebellar development.
In fact, abnormalities in cerebellar neurons are among the most
significant causes in the pathology of autism.11 Within this region,
there are at least another 9 candidate genes.6,27,32-34
In the X chromosome, the Xq22-q23 region, to which the
AGTR2 gene has been mapped, is held as important.35 Studies of
this gene have demonstrated that the deletion in this region is
associated with the high frequency of mental deficiency in autistic
individuals. However, the most significant region is Xq13-q21,
which contains one of the genes of the neuroligin family. The
neuroligins act as mediators of cell interaction (adhesion
molecules) between neurons possessing receptors for neurexin
in their plasmatic membranes. The neuroligins are found on the
post-synaptic side of the synapses36 and appear to be essential for
the efficient function of the same.37-38 Mutations in the NLGN3
and NLGN4 genes have been found in two families including
members affected by autism or Asperger’s syndrome, suggesting
that synaptic performance is affected.
Genes that encode proteins participating in the serotonin system
are also strong candidates for the study of autistic individuals.
Impaired function of this system may result in depression, epilepsy,
obsessive-compulsive behavior and affective disorders. In fact, some
of these genes, such as the serotonin transporter (5-HTT) and
serotonin receptor (5-HTR) genes, have been studied in affected
individuals. However, the relationship between the 5-HTT gene
and autism is still controversial.39-43 As for the 5-HTR genes, it has
been shown that autism is not associated with the 5-HTR2B and
5-HTR7 receptors,
44 although a significant association was found
between autism and polymorphism in the 5-HTR2A receptor gene
in autistic individuals compared to controls.
Despite all the discordance regarding candidate genes for
autism, there are still good reasons to believe that, once the
genes involved are known, new therapeutic agents may act on
specific molecular targets. In the search for these genes, identifying
multiple quantitative phenotypes is fundamental to the selection
of some regions. For example, the results of a study involving 75
families, divided into subgroups based on the speech
characteristics of the subjects and their blood relatives, suggest
that chromosomes 7 and 13 are strongly associated with autism.45
The 2q region has also been associated with autism in other
populations with speech difficulties.46-47 Such studies suggest
that social and cognitive deficits are included in the broad
phenotypic spectrum of autism.48 Social deficits include loss of
emotional response, loss of empathy, hypersensitivity and singu-
lar preoccupation with a special interest. Communication deficits,
on the other hand, consist mainly of pragmatic communication
difficulties or other types of language problems. The amplification
of the phenotypic spectrum in autism may facilitate the
identification of genes involved in the disorder. Therefore,
multidisciplinary or consortium studies are the best hope for
gaining a better understanding of PDDs. Specific diagnostic tests
are still unavailable in clinical practice. A diagnosis of autism
should result from the creation of a detailed evolutive background
of the patient, as well as from family interviews regarding the
cognitive and behavioral abilities of the patient. Future clinical
investigations will confirm whether autism is associated with the
syndromes mentioned.
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